GRAM Adds Board Member
PTSM: Pharmaceutical Technology Sourcing and Management
Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.
The Grand River Aseptic Manufacturing (GRAM) announced on Nov. 10 2015 that industry veteran Mark Kontny was elected as a member of the the board of directors.
Most recently, Kontny served as president, Pharmaceutical Development Services and chief scientific officer for Patheon. Previously, he served as divisional vice president for Abbott Laboratories, responsible for divisional staffs in Illinois, Massachusetts, Germany, and Singapore. Earlier in his career, Mark spent 10 years at Boehringer Ingelheim, working with the pre-formulation, formulation, and manufacturing of different dosage forms. He became senior director at Pfizer and helped develop small molecules and biologics in both solid-dose and parenteral forms. He worked with a biotech start-up, prior to joining Abbott.
Source: Grand River Aseptic Manufacturing
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
